Literature DB >> 25297325

Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant Enterococci.

X Zhou1, J P Arends2, G A Kampinga2, H M Ahmad2, B Dijkhuizen2, P van Barneveld2, J W A Rossen2, A W Friedrich2.   

Abstract

Rapid and accurate detection of VRE (vancomycin-resistant enterococci) is required for adequate antimicrobial treatment and infection prevention measures. Previous studies using PCR for the detection of VRE, including Cepheid's Xpert vanA/vanB assay, reported accurate detection of vanA VRE; however, many false-positive results were found for vanB VRE. This is mainly due to nonenterococcal vanB genes, which can be found in the gut flora. Our goal was to optimize the rapid and accurate detection of vanB VRE and to improve the positive predictive value (PPV) by limiting false-positive results. We evaluated the use of the Xpert vanA/vanB assay on rectal swabs and on enriched inoculated broths for the detection of vanB VRE. By adjusting the cycle threshold (CT) cutoff value to ≤ 25 for positivity by PCR on enriched broths, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 96.9%, 100%, 100%, and 99.5% for vanB VRE, respectively. As shown in this study, CT values of ≤ 25 acquired from enriched broths can be considered true positive. For broths with CT values between 25 and 30, we recommend confirming the results by culture. CT values of >30 appeared to be true negative. In conclusion, this study shows that the Cepheid's Xpert vanA/vanB assay performed on enriched inoculated broths with an adjusted cutoff CT value is a useful and rapid tool for the detection of vanB VRE.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25297325      PMCID: PMC4313300          DOI: 10.1128/JCM.01125-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Enterococcal vanB resistance locus in anaerobic bacteria in human faeces.

Authors:  T P Stinear; D C Olden; P D Johnson; J K Davies; M L Grayson
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

2.  Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay.

Authors:  Nancy Bourdon; Raphaël Bérenger; Romain Lepoultier; Audrey Mouet; Claire Lesteven; France Borgey; Marguerite Fines-Guyon; Roland Leclercq; Vincent Cattoir
Journal:  Diagn Microbiol Infect Dis       Date:  2010-07       Impact factor: 2.803

3.  Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak.

Authors:  Dorota Zabicka; Janusz Strzelecki; Agnieszka Wozniak; Pawel Strzelecki; Ewa Sadowy; Alicja Kuch; Waleria Hryniewicz
Journal:  Antonie Van Leeuwenhoek       Date:  2011-11-29       Impact factor: 2.271

4.  Molecular characterization of vanB elements in naturally occurring gut anaerobes.

Authors:  S A Ballard; K K Pertile; M Lim; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens.

Authors:  Erin S Marner; Donna M Wolk; Jeanne Carr; Carolyn Hewitt; Lorraine L Dominguez; Thomas Kovacs; Desiree R Johnson; Randall T Hayden
Journal:  Diagn Microbiol Infect Dis       Date:  2011-04       Impact factor: 2.803

6.  Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.

Authors:  Paul D Stamper; Mian Cai; Clara Lema; Kim Eskey; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-08-17       Impact factor: 5.948

7.  Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.

Authors:  Kristin Hegstad; Christian G Giske; Bjørg Haldorsen; Erika Matuschek; Kristian Schønning; Truls M Leegaard; Gunnar Kahlmeter; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

Review 8.  Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

Authors:  R Leclercq
Journal:  Clin Microbiol Infect       Date:  2009-03       Impact factor: 8.067

9.  High rates of fecal carriage of nonenterococcal vanB in both children and adults.

Authors:  M Graham; S A Ballard; E A Grabsch; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

10.  Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU.

Authors:  Guido Werner; Ingo Klare; Carola Fleige; Uta Geringer; Wolfgang Witte; Heinz-Michael Just; Renate Ziegler
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

View more
  9 in total

1.  A Single Negative Result for van Quantitative PCR on Enrichment Broth Can Replace Five Rectal Swab Cultures in Screening for Vancomycin-Resistant Enterococci.

Authors:  J M Fonville; C M C van Herk; P H A C Das; J H B van de Bovenkamp; L van Dommelen
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

Review 2.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

Review 3.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Authors:  Matthew L Faron; Nathan A Ledeboer; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

4.  Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.

Authors:  Lin Huang; Rong Zhang; Yanyan Hu; Hongwei Zhou; Junmin Cao; Huoyang Lv; Shi Chen; Shibiao Ding; Gongxiang Chen
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-30       Impact factor: 4.887

5.  Emerging resistance of van genotype in enterococci: A potential menace for therapeutic failure.

Authors:  Hasan Ejaz
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

6.  Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection.

Authors:  Zhuo-Lei Li; Qi-Bing Luo; Shan-Shan Xiao; Ze-Hong Lin; Ye-Ling Liu; Meng-Yi Han; Jing-Hua Zhong; Tian-Xing Ji; Xu-Guang Guo
Journal:  PLoS Negl Trop Dis       Date:  2021-11-08

7.  High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015.

Authors:  Sofanne J Ravensbergen; Mariëtte Lokate; Darren Cornish; Eveline Kloeze; Alewijn Ott; Alex W Friedrich; Rob van Hest; Onno W Akkerman; Wiel C de Lange; Tjip S van der Werf; Erik Bathoorn; Ymkje Stienstra
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

8.  Diagnostic Evasion of Highly-Resistant Microorganisms: A Critical Factor in Nosocomial Outbreaks.

Authors:  Xuewei Zhou; Alexander W Friedrich; Erik Bathoorn
Journal:  Front Microbiol       Date:  2017-11-03       Impact factor: 5.640

Review 9.  Enterococcus faecium: from microbiological insights to practical recommendations for infection control and diagnostics.

Authors:  Xuewei Zhou; Rob J L Willems; Alexander W Friedrich; John W A Rossen; Erik Bathoorn
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-10       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.